Portfolio company
Congruence Therapeutics
About the company
Congruence Therapeutics is a biotechnology company working at the interface of computational and experimental drug discovery.
Congruence Therapeutics is a biotechnology company working at the interface of computational and experimental drug discovery.
BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.
To find out more, consult our Policy on confidentiality.